| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e6398d6e10406d19ca78d11edfe1b25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d0f6bb150532630199891c7b6d445d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2cf3f707c5c0ac9e0e1182a3166d245 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B65D25-2811
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J7-0061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J7-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J7-0076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B65D83-0847
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B65D83-0409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5517 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
| filingDate |
2008-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a21eb406b695849c03c8832240a339e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b77e2e7b5aa6201354970c154567efa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36be994ac2e79f412f9619209389d57b |
| publicationDate |
2009-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2704929-A1 |
| titleOfInvention |
Compositions and methods for procedural sedation and analgesia using oral transmucosal dosage forms |
| abstract |
Dosage forms for procedural sedation and analgesia comprising the combination of an opioid such as sufentanil and a benzodiazepine such as triazolam for administration via the oral transmucosal route and methods for using the same are provided. |
| priorityDate |
2007-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |